Glaukos Corporation vs Pfizer, Inc. — Stock Comparison
Glaukos Corporation (GKOS) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Pfizer, Inc. narrowly edges Glaukos Corporation on Q·Score (6.2 vs 5.9 out of 10), led by Quality (6.4 vs 1.1) and Valuation (7 vs 5). Glaukos Corporation scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for GKOS (+22.7%) than for PFE (+12.6%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ currently unprofitable (-34% margin).
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
GKOS vs PFE: which stock scores better overall?
Based on Q·Score, Pfizer, Inc. (PFE) scores 6.2/10 versus Glaukos Corporation (GKOS) at 5.9/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: GKOS or PFE?
Glaukos Corporation (GKOS) scores higher on Growth (7.4/10 vs 5.1/10). Glaukos Corporation reports revenue growth (41.2% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is GKOS or PFE more attractively valued?
Pfizer, Inc. (PFE) scores higher on Valuation (7/10 vs 5/10). GKOS trades at 287.2× P/E versus PFE at 9.2×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about GKOS vs PFE?
There are 12 analysts covering GKOS with a consensus price target of $156.33, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: GKOS or PFE?
Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 1.1/10). Net profit margin: GKOS at -34.3%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: GKOS or PFE?
Glaukos Corporation (GKOS) scores higher on Financial Health (9.2/10 vs 7/10). Market beta: GKOS at 0.81, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of GKOS and PFE?
Glaukos Corporation (GKOS) has a market capitalisation of $7.5B, while Pfizer, Inc. (PFE) has a market cap of $147.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do GKOS or PFE pay dividends?
GKOS does not currently pay a dividend, while PFE pays a dividend yield of 6.61%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →